Attendee search 

Chris Britten, Managing Director, Torreya Partners (Europe) LLP

Chris is a Managing Director at Torreya Partners, a leading global investment bank focused on facilitating partnerships, M&A transactions and financings in the pharmaceutical sector worldwide.  He joined Torreya from Sanofi Pasteur-MSD where he had responsibility for all business and corporate development activities.  He is also a Non-executive Director at Phico Therapeutics Ltd.

Prior to Sanofi Pasteur-MSD, Chris held positions at Astellas (Europe) in Business and Commercial Development and several years at Deloitte Corporate Finance where he headed up the Life Science Advisory practice assisting clients across the life science sector in a wide range of transactional activities (M&A, divestments, partnering, valuation, fund-raising).  Previously, Chris was at GlaxoSmithKline where he held roles of increasing responsibility in Business Development, Corporate Ventures and R&D.  He holds a PhD in Biochemistry and an MBA in Finance.